Skip to main content

Approach to Narrow Complex Tachycardia

 



Approach to Narrow Complex Tachycardia (NCT)


Narrow Complex Tachycardia (NCT) refers to any tachyarrhythmia (heart rate >100 bpm) with a QRS duration <120 ms on the ECG. It indicates that ventricular activation is occurring via the normal His–Purkinje system, meaning the origin of the rhythm is at or above the AV node. A systematic approach helps identify the underlying mechanism, guide acute management, and prevent recurrence.


1️⃣ Step 1: Confirm It’s a Narrow Complex Tachycardia


Before labeling it NCT:


QRS <120 ms (3 small boxes) — confirms supraventricular origin.


Regular vs. Irregular rhythm — key to differential diagnosis.


Rate — often 150–250 bpm for re-entrant tachycardias; <150 for sinus tachycardia or atrial flutter with block.



Also exclude:


Artifact or sinus tachycardia due to secondary causes (fever, anxiety, hypovolemia, thyrotoxicosis, etc.).

---

2️⃣ Step 2: Classify by Rhythm Regularity


A. Regular Narrow Complex Tachycardia


Possible causes:


Sinus tachycardia

Atrioventricular Nodal Reentrant Tachycardia (AVNRT)

Atrioventricular Reentrant Tachycardia (AVRT, e.g. Orthodromic WPW)

Atrial Tachycardia

Junctional Tachycardia


B. Irregular Narrow Complex Tachycardia


Possible causes:

Atrial fibrillation (AF)

Atrial flutter with variable block

Multifocal atrial tachycardia (MAT)

---


3️⃣ Step 3: ECG Clues to Differentiate Regular NCTs

Clearly define:

Onset/Termination Gradual Sudden Sudden Sudden or gradual

P wave visibility Normal upright in II, before QRS Often hidden in QRS or short RP Retrograde P after QRS (RP < PR) P before QRS (RP > PR)

Rate (bpm) <180 140–250 150–250 100–250

Mechanism Enhanced automaticity Reentry within AV node Reentry via accessory pathway Focal atrial origin


Mnemonic:

Short RP = AVNRT/AVRT

Long RP = Atrial tachycardia or sinus tachycardia


4️⃣ Step 4: Acute Management Strategy


1. Assess Stability

Unstable (hypotension, chest pain, pulmonary edema, altered consciousness) → Immediate synchronized DC cardioversion.

2. Stable Patients

Proceed systematically:

Step 1: Vagal Maneuvers

Carotid sinus massage (if no bruit), Valsalva maneuver, modified Valsalva (leg raise after strain).


Effective for AVNRT/AVRT by increasing vagal tone.


Step 2: Adenosine

6 mg rapid IV bolus → flush → if no response, 12 mg → repeat once if necessary.


Diagnostic and therapeutic.

Caution: Avoid in irregular NCT (possible AF with accessory pathway).



Step 3: Rate or Rhythm Control

If adenosine fails, consider verapamil, diltiazem, or beta-blockers (for AVNRT/AVRT).


For atrial tachycardia, focus on treating underlying cause (e.g. digitalis toxicity, hypoxia).

---


5️⃣ Step 5: Post-Conversion Evaluation


Once sinus rhythm is restored:

12-lead ECG — look for pre-excitation (delta wave) or P-wave morphology.


Echocardiography — assess structural heart disease.

Holter monitoring or EP study — if recurrent or uncertain mechanism.


6️⃣ Step 6: Long-Term Management


Recurrent AVNRT/AVRT: Catheter ablation is first-line definitive therapy with >95% success.


Atrial tachycardia: May require ablation or antiarrhythmic drugs.


Atrial fibrillation/flutter: Manage as per CHA₂DS₂-VASc score, anticoagulation, and rhythm/rate control strategy.


Address triggers: Caffeine, stress, stimulants, thyroid disease, etc.

---


7️⃣ Quick ECG Algorithm for NCT


1️⃣ Is it regular or irregular?

→ Regular → Step 2

→ Irregular → AF/flutter/MAT


2️⃣ P waves visible?

→ Yes → Sinus or atrial tachycardia

→ No → AVNRT or AVRT likely


3️⃣ RP vs PR?

→ Short RP → AVNRT/AVRT

→ Long RP → Atrial tachycardia/sinus tachycardia



---


πŸ” Key Takeaways


Narrow QRS = supraventricular origin.


Always assess stability first — treat unstable with cardioversion.


Adenosine is both diagnostic and therapeutic in regular NCT.


Ablation offers curative therapy for recurrent AVNRT/AVRT.


Never give AV nodal blockers in irregular pre-excited tachycardias (e.g. WPW + AF).

---


πŸ«€ Summary Table


Step Key Focus Action


1 Confirm NCT QRS <120 ms

2 Rhythm Regularity Regular vs Irregular

3 P wave & RP interval Differentiate AVNRT/AVRT/AT

4 Stability Cardioversion if unstable

5 Vagal & Adenosine First-line in stable

6 Long-term plan Identify mechanism + ablation




---


πŸ“š References


1. 2023 ESC Guidelines for the Management of Supraventricular Tachycardia



2. ACC/AHA/HRS Guidelines on the Management of Patients with Arrhythmias



3. UpToDate: "Overview of narrow QRS complex tachycardias"



---


πŸ”– Hashtags


#Cardiology #El

ectrophysiology #ECG #Tachycardia #AVNRT #AVRT #AtrialTachycardia #MedicalEducation #EPApproach

Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.